Latest Strategic Outlook News

3D Energi Limited has raised $9.4 million through a share placement to fully fund the Essington-1 well drilling in Victoria’s Otway Basin, marking a pivotal step in its two-well exploration campaign.

Scorpion Minerals has addressed recent spikes in its share price and trading volume, attributing the activity to rising global gold prices and imminent assay results from its Pharos Gold Project.

Orion Minerals Ltd has been reinstated to ASX quotation following the release of its 2025 annual report and a new capital raising announcement, ending its trading suspension.

Stellar Resources has secured 100% ownership of the Granite Tor Project in northwest Tasmania, adding a promising tin and rare earth elements exploration asset adjacent to its Heemskirk Project. Historical sampling highlights significant tin and cerium anomalies, setting the stage for further exploration.

Austral Gold has lowered its 2025 production forecast for the Guanaco Mine following a workplace fatality that halted key processing operations. The company has also sold equity holdings to bolster cash flow amid operational disruptions.

Pure Hydrogen Corporation reported FY2025 revenue growth alongside a significant non-cash impairment charge, while progressing its clean hydrogen vehicle technologies and planning a spinout of its Australian gas assets.

Westgold Resources unveils a conservative, fully funded three-year plan to increase gold production from 326koz to 470koz annually by FY28 while reducing costs. The strategy leverages existing assets and processing hubs, with key expansions and exploration investments underpinning growth.

Wellnex Life Limited reported a robust 40.5% revenue increase in FY25, driven by the full-year integration of Pain Away, while margin recovery gains momentum in the second half.

Peak Rare Earths has officially been acquired by Shenghe Resources, with shareholders paid $0.443 per share and delisting from the ASX imminent. This marks a significant consolidation in the rare earths sector.

Syntara Limited has reported encouraging Phase 2a results for amsulostat combined with ruxolitinib in treating myelofibrosis, demonstrating sustained symptom improvement and spleen volume reduction over 52 weeks.

Amplitude Energy has launched the retail component of its fully underwritten entitlement offer, aiming to raise approximately A$20 million to support key growth projects including the expansion of the East Coast Supply Project and the potential restart of Patricia Baleen.

TT Investments, led by 360 Capital’s Executive Chairman Tony Pitt, has launched an unconditional off-market takeover bid for 360 Capital Group at an improved price of A$0.31 per security, signaling potential delisting and operational overhaul.